Fig. 8From: αvβ3 integrin-specific exosomes engineered with cyclopeptide for targeted delivery of triptolide against malignant melanomaBiosafety evaluation of cRGD-Exo/TP. A The body weight of tumor-bearing mice treated with normal saline, cRGD-Exo, TP solution, Exo/TP, and cRGD-Exo/TP. B The major organ index of tumor-bearing mice with different treatments. C H&E staining (200×) of primary organs harvested from the different treated mice. *p < 0.05Back to article page